Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07099365

Psychological Adjustment to Long-term (PAL) Physical Conditions: A Randomised Cross-over Feasibility Trial of a Self-guided App

This study is a two-arm, randomised controlled cross-over feasibility study with a nested, optional qualitative study. The intervention consists of a self-guided smartphone app (Orbi) based on cognitive behavioural therapy (CBT) principles, which is designed to support psychological adjustment in long-term physical conditions. Orbi is an app adaption of an existing, evidence-based web-based intervention COMPASS. The control condition consists of usual charity support (UCS) for the relevant long-term physical health conditions (LTCs). All charity support includes a helpline which can be accessed via telephone or email.

The goal of this trial is to evaluate the feasibility of Orbi and the main questions it aims to answer are:

1. Is Orbi a feasible and acceptable intervention for individuals experiencing psychological distress related to LTCs? 2. Which aspects of the Orbi app and the trial enhance or diminish participants' experiences?

Participants will:

* Be randomised and each participant has an equal (50 %) chance of being assigned either to the Orbi+UCS group or to UCS group alone for 12 weeks. After 12 weeks, they will be crossed over to the alternate condition for another 12 weeks * Complete questionnaires to assess psychological distress and intervention engagement at baseline, 6 weeks, and 12 weeks. * A subset of participants will be invited to take part in a nested, optional semi-structured interviews to explore their experiences using Orbi and participating in the study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Health Psychology Department, King's College London

London, SE1 9RT, United Kingdom

Location status: Recruiting

Location contact

Rona Moss-Morris, PhD

CONTACT

[email protected]

+44 (0)20 7188 ext. 0178

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged ≥18-years
  • Verbal and written proficiency in English
  • United Kingdom resident (General Practitioner registered)
  • Basic computer literacy
  • Email address to register with Orbi
  • Have a long-term physical health condition
  • Are experiencing distress related to their long-term physical condition

Exclusion criteria

  • Evidence of substance dependency, cognitive impairment, severe mental health conditions identified by adhering to usual care Improving Access to Psychological Therapies (IAPT) screening practices that are employed at assessment and triage
  • Those with evidence of severe depression and/ or anxiety scoring over 6 on the Patient Health Questionnaire-4 (PHQ-4) eligibility questionnaire or scoring 1 or above on the eligibility Patient Health Questionnaire-9 (PHQ-9) suicide risk question
  • Receiving active psychological treatment from psychologist/counsellor/therapist or online psychological intervention

Treatment and study plan

Orbi

Device

Orbi is adapted from COMPASS, a web-based cognitive behavioural therapy (CBT) intervention based on the Transdiagnostic Model of Adjustment in Long-Term (physical) Conditions Model. Orbi is made up of 13 topics, each exploring a different challenge faced by individuals with a LTC(s). Orbi is a self-guided CBT programme with no therapist involvement.

Primary outcomes

  1. Recruitment

    Time frame: At baseline

    Frequencies and percentages of the number of potential participants recruited to the study

  2. Retention

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    Frequencies and percentages of the number of participants retained in the study

  3. Reach

    Time frame: At baseline

    Frequencies and percentages of recruited participants who are from under-represented ethnic groups for research conducted in the United Kingdom (e.g. ethnic groups other than white British)

  4. Acceptability

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    Quantitative: Frequencies and percentages or means and standard deviations of the Theoretical Framework of Acceptability (TFA) questionnaire

    Qualitative: Framework Thematic Analysis

Secondary outcomes

  1. App usability

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    Qualitative: Usability of the app will be evaluated within the interviews and Framework Thematic Analysis.

  2. Primary adherence and engagement: App usage data

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    Frequencies and percentages or means and standard deviations of:

    Number of intervention sessions accessed and/or completed; time spent or time to completion, number of log-ins, pages viewed.

  3. Compare post intervention scores on Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS-15) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A 15-item scale assessing symptoms of anxiety and depression. It includes items from the Patient Health Questionnaire Scale (PHQ-8) for depression and the Generalised Anxiety Disorder Scale (GAD-7) for anxiety, each scored on a 4-point Likert scale from 'not at all' (0) to 'nearly every day' (3). Total scores range from 0 to 45 with higher scores indicating greater symptom severity.

  4. Compare post intervention scores on Patient Health Questionnaire Scale - (PHQ-8) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    8-item questionnaire scoring the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for depression on 4-point Likert scales from 'not at all' (0) to 'nearly every day' (3). Total scores below 5, 10, 15, 20, and up to 24 are categorised as none-to-minimal, mild, moderate, moderately severe, and severe depression.

  5. Compare post intervention scores on Generalised Anxiety Disorder Scale (GAD-7) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A 7-item questionnaire assessing the severity of generalised anxiety symptoms based on DSM-IV criteria. Each item is scored on a 4-point Likert scale from 'not at all' (0) to 'nearly every day' (3). Total scores range from 0 to 21, with cut-off points at 5, 10, and 15, indicating mild, moderate, and severe anxiety, respectively.

  6. Compare post intervention scores on Illness Related Distress (IRD) scale adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A 14-item scale assessing how a long-term physical health condition has affected the psychological distress experienced by an individual over the last two weeks. Intrapersonal IRD = items 1-7 (cut-off = 15); Interpersonal IRD = items 8-14 (cut-off = 12).

    The scale is augmented by 3 additional items. Two horizontal visual analogue scales ranging from 0 to 10: One indicating the amount of psychological distress that is attributed to having one or more physical Long Term Condition (LTC) over the last two weeks; one indicating the severity of psychological distress related to the LTC over the last two weeks. The final item asks the respondent to specify which LTC they are attributing their psychological distress to (as many people are affected by multiple LTCs in parallel).

  7. Compare post intervention scores on Work and Social Adjustment Scale (WSAS) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A 5-item scale measuring the impact of mental health issues on daily functioning across work, home management, social leisure, private leisure, and close relationships. Each item is scored from 0 (no impairment) to 8 (severe impairment). Total score ranges from 0 to 40, with higher scores indicating greater functional impairment.

  8. Compare post intervention scores on EuroQol 5-Dimension 3-Level Questionnaire (EQ-5D-3L) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A 5-item scale measuring health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension is rated on three levels (1 to 3). Total score ranges from 5 to 15, with higher scores indicating more severe issues in health-related quality of life.

  9. Compare post intervention scores on Patient Enablement Instrument (PEI) adjusting for baseline differences between groups

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    A 6-item questionnaire assessing patient enablement (i.e. patients' ability to understand and cope with their health and illness) on a 4-point scale (much better, better, same or less, not applicable). Total scores range from 0 to 12, with higher scores indicating greater patient enablement.

  10. Compare post intervention scores on Patient Global Impression of Severity (PGI-S) adjusting for baseline differences between groups

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    A one-item questionnaire assessing perceived severity of participants' long-term physical conditions using a 4-point scale with scoring ranges from 0 to 3. Higher scores indicate greater severity.

  11. Compare post intervention scores on Patient Global Impression of Improvement (PGI-I) adjusting for baseline differences between groups

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    A one-item questionnaire assessing how patient's health condition has changed since the beginning of the study on a 7-point scale with scoring ranges from 0 to 6. Higher scores indicate greater deterioration.

  12. Comparison between intervention and control groups on Health Service Utilisation

    Time frame: At baseline, 6 weeks (mid-study) and 12 weeks (end of study)

    Usage of health services will be captured with the Health Service Use Questionnaire. Participants will indicate whether they have accessed key services, including general practitioner (GP), psychological or counselling services, and emergency care during the past 3 months. For each service reported, additional items capture (i) the number of contacts, (ii) the mode of contact (e.g., in-person, telephone, video), and (iii) the duration of the most recent contact.

  13. Comparison between intervention and control in access of charity services

    Time frame: 6 weeks (mid-study) and 12 weeks (end of study)

    Participants will also be asked about their access of charity resources. A multiple-selection drop-down box will show the following options (charity helpline, online forums/networks/phone counselling, information booklets, others)

Study contacts

Contact information is provided by the study sponsor or research team.

Rona Moss-Morris, PhD

CONTACT

[email protected]

+44 (0)20 7188 ext. 0178

Sponsors and collaborators

Lead sponsor

King's College London

Other

Collaborators

  • Avegen Health

Registry information

Official study title

A Randomised Controlled Cross-over Feasibility Trial of a Self-guided Smartphone App to Support Psychological Adjustment in Long-term Physical Conditions Compared to Usual Charity Support

Acronym: PAL

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Aug 1, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.